These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 10353302)

  • 1. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
    Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M; Jarvis B
    Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
    Lamb HM; Culy CR; Faulds D
    Pharmacoeconomics; 2000 Nov; 18(5):487-510. PubMed ID: 11151402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
    Dunn CJ; Goa KL
    Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
    Stoloff SW; Srebro SH; Edwards LD; Johnson MC; Rickard KA
    MedGenMed; 2001 Jun; 3(3):2. PubMed ID: 11549975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
    Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
    J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA; Lyseng-Williamson KA; Wiseman LR
    Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.